$SLQT

SelectQuote, Inc. (SLQT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of SelectQuote, Inc. (NYSE: SLQT) investors. The investigation focuses on whether SelectQuote and its officers engaged in corporate wrongdoing, specifically for those who purchased securities before September 9, 2020, and continue to hold them. The firm encourages affected stockholders to contact them to learn more and potentially assist in the investigation, offering their services on a contingency fee basis.

Original reporting
Published Mar 13, 2026, 7:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 13, 2026, 8:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SelectQuote, Inc. (SLQT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation — source image
Decision brief

The 30-second read

$SLQTBearishMed
01

Why it matters

The investigation has led to a bearish sentiment, likely causing short-term price declines and increased volatility.

02

Market read

The news is highly relevant for traders holding or considering trading SLQT, with immediate implications for investor sentiment and risk management.

03

What to watch

Potential for legal resolution or settlement that could mitigate negative impact; overall market conditions and sector trends should also be considered.

Timing: Immediate, as news is recent and ongoing investigation may influence trading decisions today.

Background

SelectQuote, Inc. is under investigation for potential corporate misconduct, which could impact its stock performance and investor confidence.

Company-level read

Ticker impact

$SLQTBearishMedium confidence
Context

High relevance due to ongoing investigation affecting investor sentiment.

Expected impact

Moderate short-term decline of approximately 5-10%, contingent on investigation developments.

Evidence & confidence

The bearish sentiment score indicates a notable negative perception, but the lack of specific financial data or legal outcomes limits the certainty of price movement predictions.

Market effects

Potential negative impact on the financial services sector due to reputational concerns.

Limited regional impact; primarily affects US-based investors and markets.

Minimal, as the news pertains to a US-listed company and legal investigation.

Counterpoint

The investigation may be a temporary setback; if legal issues are resolved favorably, the stock could rebound.

Key entities

  • SelectQuote, Inc.

    A provider of insurance comparison and sales services.

  • Bronstein, Gewirtz & Grossman, LLC

    Legal firm conducting the investigation.

Related articles

$SLQTHighAI 8/10

Why is Selectquote stock sliding today?

Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.

$RBAHigh

Why This U.S. Auto Retail Stock is Barclays’ Top Pick Right Now

Barclays named RB Global Inc (RBA) its top U.S. auto retail pick, citing an attractive valuation at 12.7x EV/EBITDA, market share gains, and cyclical improvements in its Heavy Equipment & Transportation segment. RBA reported Q2 2026 revenue of $1.32B, beating estimates, with 11% gross transaction value growth. Barclays expects RBA to gain market share from Copart Inc (CPRT) in the salvage vehicle auction market.

$GHHighAI 8/10

Guardant ordered to pay $245m in DNA sequencing patent dispute

Guardant Health was ordered to pay $245.2m to TwinStrand Biosciences and the University of Washington for patent infringement. The ruling covers 11 products, including Guardant360 CDx, and includes damages, royalties, and interest. Guardant plans to appeal, while TwinStrand affirms its commitment to its intellectual property.

$KURAMed

Why is Kura Oncology stock surging today?

Kura Oncology's stock rose 11.6% in pre-market trading after CEO Troy Wilson bought 100,000 shares for $1.24 million, his second large purchase in a week. Analysts Citigroup and Jefferies reaffirmed positive ratings, citing strong commercial momentum for KOMZIFTI and Q2 earnings beat. The stock surpassed its 52-week high of $12.90.

$BEMed

Nancy Pelosi Made Millions On Nvidia Options. Now She’s Betting $3 Million On 1 AI Energy Stock

Paul Pelosi, spouse of House Speaker Nancy Pelosi, acquired 15,000 shares and 200 call options of Bloom Energy (BE) in July 2026, with a potential investment ranging from $3 million to $12 million. Bloom Energy reported Q2 2026 revenue of $1.065 billion, up 165.5% year-over-year, and raised full-year guidance to $3.9 billion to $4.2 billion. The stock closed at $204.02 on August 24, 2026, up 134.8% year-to-date. The Pelosi household also added to an existing Intel (INTC) position.